Marinus Pharmaceuticals reported $-19078000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
ALKERMES ALKS:US $ -0.27M 23.16M
Amgen AMGN:US $ 3228M 40M
Aptinyx Inc APTX:US $ -21106000 1.34M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Biogen BIIB:US $ 991.8M 155.8M
Eisai 4523:JP Y 15346M 49516M
Esperion Therapeutics ESPR:US $ -55592000 23.21M
Gilead Sciences GILD:US $ 4370M 1605M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Marinus Pharmaceuticals MRNS:US $ -19.08M 4.32M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Supernus Pharmaceuticals SUPN:US $ 38.61M 2.15M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M
Zogenix ZGNX:US $ -51.9M 1.17M